Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Be patient, as noticeable effects may take time
Yes, its activation of the MC4R, a key receptor in regulating energy homeostasis, has made it a subject of interest in metabolic and obesity research
Bariatric surgery is covered by many commercial insurance plans and Medicare and Medicaid, but bariatric endoscopy may not be covered
LD211 was used as a selective agonist for MC1-R (compound 28 in the original publication) (Doedens et al, 2010), [D-Trp8]--MSH as a selective MC3-R agonist (Grieco et al, 2000), THIQ as a selective MC4-R agonist (Cayman Chemical, USA, # 312637-48-2) (Sebhat et al, 2002), and PG-901 as a selective MC5-R agonist (Grieco et al, 2002)
US$ 24.97
US$ 27.46
US$ 29.91
US$ 22.53
US$ 29.75
US$ 24.60
